IL6 and COVID-19: A characteristic problem occurring in coronavirus disease 2019 (COVID-19) are excessive elevations of pro-inflammatory cytokines such as interleukin-6 (IL-6) and C-reactive protein (CRP) which are associated with worse clinical courses (1, 2).